Related Experiment Video
Updated: Aug 18, 2026

RNA Fluorescence In Situ Hybridization for Long Non-Coding RNA Localization in Human Osteosarcoma Cells
Published on: June 16, 2023
[Therapeutic effects of RNA interference targeting HIF-1 alpha gene on human osteosarcoma]
Qiang Wu1, Shu-Hua Yang, Shu-Nan Ye
1Department of Orthopaedic, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430022, China.
Objective:
To investigate the inhibition effect of the small hairpin RNA (shRNA) targeting HIF-1alpha gene on the growth of osteosarcoma in vitro and in vivo.
Methods:
The small hairpin RNA (shRNA) eukaryotic expression vector targeting HIF-1alpha gene, named pSilencer-HIF, was constructed and transfected into cultured human osteosarcoma cell of line SaOS-2 via liposome reagent. Then the osteosarcoma cells were cultured under chemical hypoxia conditions. The inhibition effects on HIF-1alpha gene were determined by semi-quantitative reverse transcription PCR and Western blot analysis. The in vitro cellular growth activities were assayed by MTT colorimetry. The cell apoptosis was studied by electron microscopy, TUNEL assay, and annexin V/PI double staining. Eighteen Balb/C mice were randomly divided into 3 equal groups to be inoculated with SaOS-2/shRNA, SaOS-2/neo (blank vector), or SaOS-2 subcutaneously respectively and then the appearance and size of tumors were observed. Four weeks later the mice were killed and the volumes of tumor were calculated so as to evaluate the therapeutic effects of shRNA.
Results:
The successful construction of pSilencer-HIF plasmid was identified with sequencing. After the shRNA expression vector was transfected into the SaOS-2 cells, the expression of HIF-1alpha gene was inhibited significantly (by 90%). The cellular growth activities in the SaOS-2 cells transfected with pSilencer-HIF plasmid decreased obviously in hypoxia culture. After 72 hours of exposure to hypoxia, electron microscopy and TUNEL assay showed classic apoptosis characters in the SaOS-2 cells transfected with pSilencer-HIF plasmid with an apoptosis rate of 18.71% +/- 0.98%, significantly higher than those in the negative control group transfected with pSilencer-neo and in the nontransfected group (both P < 0.01). The growth speed and formation rate of xenograft tumor in pSilencer-HIF transfected mice slowed down significantly. A lot of necrotic tissues could be observed in the pSilencer-HIF transfected group by HE staining, however, there was no similar inhibitive effect in the control groups.
Conclusion:
shRNA targeting HIF-1alpha gene blocks the hypoxia transduction pathway efficiently and inhibits the growth of osteosarcoma cells.
Insights
Small hairpin RNA (shRNA) targeting the HIF-1alpha gene effectively inhibits osteosarcoma growth by blocking hypoxia pathways. This study demonstrates significant reductions in tumor growth and increased apoptosis in vitro and in vivo.
Area of Science:
- Molecular Biology
- Oncology
- Gene Therapy
Context:
- Osteosarcoma is a primary bone malignancy with limited treatment options.
- Hypoxia-inducible factor 1-alpha (HIF-1alpha) is a key regulator in tumor development and progression.
- Targeting HIF-1alpha presents a potential therapeutic strategy for osteosarcoma.
Purpose:
- To investigate the inhibitory effect of small hairpin RNA (shRNA) targeting the HIF-1alpha gene on osteosarcoma growth.
- To evaluate the efficacy of shRNA-mediated HIF-1alpha inhibition in vitro and in vivo models.
Summary:
- A shRNA eukaryotic expression vector (pSilencer-HIF) targeting HIF-1alpha was constructed and transfected into SaOS-2 osteosarcoma cells.
- Transfection significantly inhibited HIF-1alpha expression (90%), reduced cell growth, and induced apoptosis under hypoxic conditions.
- In vivo studies showed that pSilencer-HIF transfection significantly slowed xenograft tumor growth and increased necrosis in mice.
Impact:
- shRNA targeting HIF-1alpha effectively blocks the hypoxia transduction pathway.
- This approach demonstrates significant inhibition of osteosarcoma cell growth and tumor formation.
- Provides a potential gene therapy strategy for osteosarcoma treatment.
Related Concept Videos
Experimental RNAi
RNA Interference
This process occurs naturally in cells, often through the activity of genomically-encoded microRNAs. Researchers can take advantage of this mechanism by introducing synthetic RNAs to deactivate specific genes for research or therapeutic purposes. For example, RNAi could be used...
RNA Interference
This process occurs naturally in cells, often through the activity of genomically-encoded microRNAs. Researchers can take advantage of this mechanism by introducing synthetic RNAs to deactivate specific genes for research or therapeutic purposes. For example, RNAi could be used...
siRNA - Small Interfering RNAs
In the cytoplasm, siRNA is processed from a double-stranded RNA, which comes from either endogenous DNA transcription or exogenous sources like a virus. This double-stranded RNA is then cleaved by the ATP-dependent...
Inhibitors of Viral Protein Synthesis
Targeted Cancer Therapies
There are several types of targeted therapies against specific...
